Location History:
- Choisy le Roi, FR (2017)
- Paris, FR (2013 - 2020)
Company Filing History:
Years Active: 2013-2020
Title: Magali Mathieu: Innovator in Antibody Engineering
Introduction
Magali Mathieu is a prominent inventor based in Paris, France. She has made significant contributions to the field of biotechnology, particularly in the development of engineered antibodies. With a total of five patents to her name, her work focuses on innovative solutions for medical applications.
Latest Patents
Among her latest patents is the invention of engineered anti-TGF-β antibodies and antigen-binding fragments. These antibodies are designed to selectively bind to different isoforms of Transforming Growth Factor-β (TGF-β), which is crucial for various therapeutic applications. Another notable patent involves antibodies that specifically bind to Plasminogen Activator Inhibitor type-1 (PAI-1). This invention includes pharmaceutical compositions and methods for modulating PAI-1 activity, which can be utilized in both in vitro and in vivo settings.
Career Highlights
Magali has worked with renowned companies such as Sanofi and Genzyme Corporation. Her experience in these organizations has allowed her to refine her expertise in antibody engineering and contribute to groundbreaking research in the field.
Collaborations
Throughout her career, Magali has collaborated with notable colleagues, including Ronnie Rong Wei and Aaron Moulin. These partnerships have further enhanced her research and development efforts in antibody technology.
Conclusion
Magali Mathieu stands out as an influential inventor in the biotechnology sector, with her innovative patents paving the way for advancements in medical treatments. Her dedication to research and collaboration continues to drive progress in the field of antibody engineering.